Clinical Research Directory
Browse clinical research sites, groups, and studies.
Insulin Therapy for Postreperfusion Hyperglycemia
Sponsor: Seoul National University Hospital
Summary
Glycemic control during liver transplantation is challenging especially after reperfusion of the liver graft. Insulin dose to treat postreperfusion hyperglycemia is retrospectively analyzed using historical data. The proposed dose then is prospectively applied to the patients to assess the adequacy of the insulin dose.
Official title: Insulin Therapy for Postreperfusion Hyperglycemia in Liver Transplantation
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2017-05-15
Completion Date
2024-12-31
Last Updated
2024-04-19
Healthy Volunteers
No
Interventions
Insulin
If blood glucose level after reperfusion of liver graft exceeds 180 mg/dL, the insulin dose proposed by the linear mixed effects analysis is given as a bolus.
Locations (1)
Seoul National University Hospital
Seoul, South Korea